Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival

BACKGROUND: Guidelines do not recommend surgery for patients with oligometastatic disease from esophagogastric adenocarcinoma (EGAC), although some studies suggest a more favorable survival. We analyzed the outcome of oligometastatic EGAC receiving FLOT chemotherapy followed by surgery. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Runkel, Mira, Verst, Rasmus, Spiegelberg, Julia, Fichtner-Feigl, Stefan, Hoeppner, Jens, Glatz, Torben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805136/
https://www.ncbi.nlm.nih.gov/pubmed/33435947
http://dx.doi.org/10.1186/s12893-020-01035-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805136/
https://www.ncbi.nlm.nih.gov/pubmed/33435947
http://dx.doi.org/10.1186/s12893-020-01035-9

Ejemplares similares